The clinical information you need, at your fingertips.

Medical News for You

FDA

FDA approves Fayuvi gene therapy, first treatment for Sanfilippo syndrome type A

The single-dose treatment targets the enzyme deficiency underlying a rare inherited disorder that causes progressive loss of cognitive, language, and motor function. . .

Obstet Gynecol

New toolkit helps clinicians navigate perimenopause hormone choices

Guidance highlights when to use hormonal contraception, menopause hormone therapy, or both for symptom management and cycle control. . .

HHS

12h

USPSTF refill draws AMA warning over lack of primary care

The eight appointees restore the panel that grades preventive services to its full 16 members, a slate the physicians' group says departs from the primary care membership behind the task force's credibility. . .

JAMA Netw Open

13h

Primary care panel load tied to clinician burnout

An access-expansion push that filled VA panels past calculated capacity was accompanied by more clinician burnout and intention to leave. . .

Science

15h

Generalist AI helped radiologists catch 10% more on abdominal CT

Previous imaging AI models handled one disease per model; this system covered 146 findings across 18 organs and held up in emergency scans it never trained on. . .

N Engl J Med

16h

Can high-risk adenoma surveillance wait 5 years?

Trial challenges the long-standing 3-year colonoscopy interval after removal of high-risk adenomas. . .

Diabetes Care

18h

CGM flags cardiometabolic risk in people without diabetes

Certain glucose patterns, particularly time spent above 140 mg/dL, were linked to higher cardiovascular risk, hypertension, and dyslipidemia. . .

FDA

19h

FDA approves Bexlutry, first radioligand equivalent for gastroenteropancreatic neuroendocrine tumors

New targeted radionuclide option may expand access to somatostatin receptor–directed care for adults with these uncommon malignancies. . .

JAMA Cardiol

21h

Semaglutide’s cardiovascular benefits hold up with frailty

More frail participants also had greater quality-of-life gains and favorable changes in frailty scores. . .